The importance of early development strategy and planning for biologic patent term extension.
Micheal Binns
Advertisement
Articles by Micheal Binns
Advertisement
Latest Updated Articles
- Early-Development Strategy for PTE in Biologics Given Unknowns in the Law
Published: July 3rd 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Is FDA Streamlining Regulations in the Biosimilar Space?
2
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
5
